SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-14-000853
Filing Date
2014-02-14
Accepted
2014-02-14 06:09:56
Documents
11
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1213_tianyinpharma.htm 10-Q 587466
2 CERTIFICATION f10q1213ex31i_tianyinphar.htm EX-31.1 14616
3 CERTIFICATION f10q1213ex31ii_tianyinphar.htm EX-31.2 14438
4 CERTIFICATION f10q1213ex32i_tianyinphar.htm EX-32.1 5854
5 CERTIFICATION f10q1213ex32ii_tianyinphar.htm EX-32.2 6130
  Complete submission text file 0001213900-14-000853.txt   2802732

Data Files

Seq Description Document Type Size
6 tpi-20131231.xml EX-101.INS 354668
7 tpi-20131231.xsd EX-101.SCH 20665
8 tpi-20131231_cal.xml EX-101.CAL 44826
9 tpi-20131231_def.xml EX-101.DEF 30219
10 tpi-20131231_lab.xml EX-101.LAB 207263
11 tpi-20131231_pre.xml EX-101.PRE 120122
Mailing Address 23RD FLOOR, UNIONSUN YANGKUO PLAZA NO.2, BLOCK 3, RENMIN ROAD SOUTH CHENGDU, P.R. F4 610041
Business Address 23RD FLOOR, UNIONSUN YANGKUO PLAZA NO.2, BLOCK 3, RENMIN ROAD SOUTH CHENGDU, P.R. F4 610041 0086-028-86154737
TIANYIN PHARMACEUTICAL CO., INC. (Filer) CIK: 0001362718 (see all company filings)

IRS No.: 204857782 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-34189 | Film No.: 14609327
SIC: 2834 Pharmaceutical Preparations